Comparing Omnipaque 350 vs Ultravist
| Omnipaque 350 (iohexol) | Ultravist (iopromide) |
|
|---|
| Omnipaque 350 (iohexol) | Ultravist (iopromide) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Body Imaging, Aortography, Angiocardiography, Arthrography, Cerebral Arteriography, Cystourethrography, Digital Subtraction Angiography, Gastrointestinal Tract Examination, Head... View more |
Prescription only
Prescribed for Computed Tomography, Cerebral Arteriography, Coronary Arteriography, Intra-arterial Digital Subtraction Angiography, Left Ventriculography, Peripheral Arteriography, Urography... View more |
Related suggestions Urography
|
|||||||||||||||
| More about Omnipaque 350 (iohexol) | More about Ultravist (iopromide) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Omnipaque 350 has an average rating of 5.8 out of 10 from a total of 4 ratings on Drugs.com. 25% of reviewers reported a positive effect, while 25% reported a negative effect. |
Ultravist has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Omnipaque 350 side effects |
View all Ultravist side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Omnipaque 350 prices |
View all Ultravist prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other iohexol brands include: Omnipaque 12, Omnipaque 140, Omnipaque 180, Omnipaque 180 Redi-Unit, Omnipaque 210, Omnipaque 240, Omnipaque 240 Redi-Unit, Omnipaque 300, Omnipaque 9, Omnipaque Flexipak, Oraltag View more |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
12 hours |
12 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 328 drugs are known to interact with Omnipaque 350:
|
A total of 149 drugs are known to interact with Ultravist:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
May 10, 1995 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.